Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-022690
Filing Date
2014-06-04
Accepted
2014-06-04 16:47:22
Documents
1
Period of Report
2014-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd410985.html 4  
1 FORM 4 rrd410985.xml 4 3742
  Complete submission text file 0001181431-14-022690.txt   5113
Mailing Address 4400 BISCAYNE BOULEVARD SUITE 950 MIAMI FL 33137
Business Address
Lockshin Curtis (Reporting) CIK: 0001383556 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36304 | Film No.: 14891469

Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations